Regardless of whether a tumor is IDH-mutant or IDH-wild type, PKM2 expression remains consistent, indicating that PKM2 may not be directly influenced by the IDH mutation in the context of GBM and ASTROG4. Here, IDH1 is linked to glioblastoma.